US4175204A - Method of preparing E-4-acetoxy-2-methyl-2-butenal - Google Patents
Method of preparing E-4-acetoxy-2-methyl-2-butenal Download PDFInfo
- Publication number
- US4175204A US4175204A US06/001,075 US107579A US4175204A US 4175204 A US4175204 A US 4175204A US 107579 A US107579 A US 107579A US 4175204 A US4175204 A US 4175204A
- Authority
- US
- United States
- Prior art keywords
- methyl
- reaction mixture
- acetate
- buten
- acetoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- LPDDKAJRWGPGSI-ZZXKWVIFSA-N [(e)-3-methyl-4-oxobut-2-enyl] acetate Chemical compound CC(=O)OC\C=C(/C)C=O LPDDKAJRWGPGSI-ZZXKWVIFSA-N 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 title claims description 25
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 36
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 claims abstract description 22
- 230000000269 nucleophilic effect Effects 0.000 claims abstract description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 37
- 239000011541 reaction mixture Substances 0.000 claims description 26
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 24
- 230000008569 process Effects 0.000 claims description 17
- 230000015572 biosynthetic process Effects 0.000 claims description 14
- KUGZCVGTOJHJEU-UHFFFAOYSA-N (4-bromo-3-methylbut-2-enyl) acetate Chemical group CC(=O)OCC=C(C)CBr KUGZCVGTOJHJEU-UHFFFAOYSA-N 0.000 claims description 13
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical group [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 13
- WFDIJRYMOXRFFG-UHFFFAOYSA-N acetic acid anhydride Natural products CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 12
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims description 11
- 239000007795 chemical reaction product Substances 0.000 claims description 11
- 238000003786 synthesis reaction Methods 0.000 claims description 9
- 229910052736 halogen Inorganic materials 0.000 claims description 8
- 150000002367 halogens Chemical class 0.000 claims description 8
- URVYVINLDPIJEH-UHFFFAOYSA-N (4-chloro-3-methylbut-2-enyl) acetate Chemical compound CC(=O)OCC=C(C)CCl URVYVINLDPIJEH-UHFFFAOYSA-N 0.000 claims description 7
- VUQIEMOGCCDRND-UHFFFAOYSA-N 1-chloro-2-methylbut-3-en-2-ol Chemical compound ClCC(O)(C)C=C VUQIEMOGCCDRND-UHFFFAOYSA-N 0.000 claims description 7
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 6
- 239000003377 acid catalyst Substances 0.000 claims description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 5
- QFZDPMPJNIGOAT-UHFFFAOYSA-N (1-bromo-2-methylbut-3-en-2-yl) acetate Chemical compound CC(=O)OC(C)(CBr)C=C QFZDPMPJNIGOAT-UHFFFAOYSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 claims description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 150000003842 bromide salts Chemical class 0.000 claims description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 2
- 239000008363 phosphate buffer Substances 0.000 claims description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims 2
- 239000001569 carbon dioxide Substances 0.000 claims 1
- 229910002092 carbon dioxide Inorganic materials 0.000 claims 1
- 229940111685 dibasic potassium phosphate Drugs 0.000 claims 1
- 229940061607 dibasic sodium phosphate Drugs 0.000 claims 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 23
- -1 allylic halide Chemical class 0.000 abstract description 10
- 238000002360 preparation method Methods 0.000 abstract description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 33
- 239000000203 mixture Substances 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 13
- 229960000583 acetic acid Drugs 0.000 description 11
- 150000001299 aldehydes Chemical class 0.000 description 10
- 238000007254 oxidation reaction Methods 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 125000000746 allylic group Chemical group 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 230000003647 oxidation Effects 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 239000012362 glacial acetic acid Substances 0.000 description 5
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 238000004508 fractional distillation Methods 0.000 description 3
- 238000006317 isomerization reaction Methods 0.000 description 3
- 229910001463 metal phosphate Inorganic materials 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- JSCUZAYKVZXKQE-JXMROGBWSA-N (2e)-1-bromo-3,7-dimethylocta-2,6-diene Chemical compound CC(C)=CCC\C(C)=C\CBr JSCUZAYKVZXKQE-JXMROGBWSA-N 0.000 description 2
- BWZVCCNYKMEVEX-UHFFFAOYSA-N 2,4,6-Trimethylpyridine Chemical compound CC1=CC(C)=NC(C)=C1 BWZVCCNYKMEVEX-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229910004861 K2 HPO4 Inorganic materials 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 125000001475 halogen functional group Chemical group 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- JCZMXVGQBBATMY-UHFFFAOYSA-N nitro acetate Chemical compound CC(=O)O[N+]([O-])=O JCZMXVGQBBATMY-UHFFFAOYSA-N 0.000 description 2
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- IXZDIALLLMRYOU-UHFFFAOYSA-N tert-butyl hypochlorite Chemical compound CC(C)(C)OCl IXZDIALLLMRYOU-UHFFFAOYSA-N 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- MNXHWLCDKNYQDY-UHFFFAOYSA-N 1-bromooctadec-2-ene Chemical compound CCCCCCCCCCCCCCCC=CCBr MNXHWLCDKNYQDY-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- DHONOAPSAYTYAY-UHFFFAOYSA-N 4-(2-bromoethylidene)heptane Chemical compound CCCC(CCC)=CCBr DHONOAPSAYTYAY-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- WSNMPAVSZJSIMT-UHFFFAOYSA-N COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 Chemical compound COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 WSNMPAVSZJSIMT-UHFFFAOYSA-N 0.000 description 1
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
- 229910019093 NaOCl Inorganic materials 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 101150108015 STR6 gene Proteins 0.000 description 1
- 101100386054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CYS3 gene Proteins 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical class [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- LPDDKAJRWGPGSI-UTCJRWHESA-N [(z)-3-methyl-4-oxobut-2-enyl] acetate Chemical compound CC(=O)OC\C=C(\C)C=O LPDDKAJRWGPGSI-UTCJRWHESA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 description 1
- 238000010960 commercial process Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000002027 dichloromethane extract Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000012011 nucleophilic catalyst Substances 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000005375 primary alkyl halides Chemical class 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229910001494 silver tetrafluoroborate Inorganic materials 0.000 description 1
- 238000001577 simple distillation Methods 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 101150035983 str1 gene Proteins 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical class C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/64—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by simultaneous introduction of -OH groups and halogens
- C07C29/66—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by simultaneous introduction of -OH groups and halogens by addition of hypohalogenous acids, which may be formed in situ, to carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
- C07C67/29—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by introduction of oxygen-containing functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
- C07C67/293—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
Definitions
- Reif et al. have described a commercial process for the production of Vitamin A acetate [Chemie-Ing.-Techn. 45, 646-652 (1973)].
- the final step of the synthesis involves a reaction between a C 15 triphenylphosphonium salt and a C 5 acetate: ##STR1##
- a method for preparing the C 5 acetate i.e., ⁇ -formylcrotyl acetate, systematically named E-4-acetoxy-2-methyl-2-butenal
- Reif et al. show a multi-step process involving an oxidation reaction: ##STR2##
- the Reif et al. synthesis is suggested in U.S. Pat. No. 3,478,060, and in the references cited therein.
- the present invention relates to an improved process for producing E-4-acetoxy-2-methyl-2-butenal, a C 5 acetate which can be used in Vitamin A synthesis.
- practice of the method of the invention utilizes easily available isoprene and acetic acid as starting materials, proceeds at room temperature, requires only two reaction steps, and yields substantially quantitative amounts of the desired C 5 acetate according to the following reaction scheme: ##STR3##
- An initial step in applicant's process of synthesizing E-4-acetoxy-2-methyl-2-butenal involves the preparation of a 4-halo-3-methyl-2-buten-1-ol acetate intermediate.
- This intermediate may be prepared directly, in a one-step reaction by the addition of a source of positive halogen, X+, to a solution of isoprene in acetic acid according to a process described by applicant and his co-worker [J. Babler and W. Buttner, Tetrahedron Lett., 239 (1976)].
- the first step involves the synthesis of 1-chloro-2-methyl-3-buten-2-ol, which may be synthesized from isoprene in accordance with a process suggested in British Patent 978,892 to Dunlop Rubber Company: ##STR5## Another route to this intermediate is suggested elsewhere in the literature [Chem. Abstracts, 80, 59,36ly (1974)].
- the DMSO oxidation of the primary allylic chloride to the desired ⁇ -formylcrotyl acetate will be successful when a different non-nucleophilic base is utilized in the reaction--a dibasic metal phosphate such as Na 2 HPO 4 or K 2 HPO 4 : ##STR8##
- a bromide salt such as sodium bromide and a monobasic metal phosphate buffer is desirable, but not necessary.
- N-bromosuccinimide N-bromosuccinimide
- the desired 1,2- and 1,4-adducts can be removed from the reaction mixture by continuous extraction with heptane or hexane.
- the acetic acid in turn, can be removed from the remaining aqueous layer by continuous extraction with benzene, ether, or chloroform.
- the resultant aqueous layer will contain succinimide. If one equivalent of sodium hydroxide is added to the aqueous solution and the solution cooled to 0° C., addition of one equivalent of bromine will produce N-bromosuccinimide which quickly precipitates out of the aqueous medium and which may be recycled in the reaction.
- K a ⁇ 10 -2 strong acid catalysts such as sulfuric acid can be used to effect this transformation.
- the product was isolated by pouring the mixture into ice-cold aqueous sodium hydroxide (enough to neutralize the acetic acid) and extracting with ether. (The product can also be isolated by diluting the mixture with 10 volumes of iced water and continuous extraction with cyclohexane.) The yield of 1° allylic acetate (containing no 3° acetate) was 1.94 g. (11.94 mmoles, 86% yield).
- the desired C 5 acetate may be prepared by the general synthetic steps consisting of: (a) forming a first reaction mixture of isoprene, acetic acid, and a source of positive halogen; (b) isolating 4-halo-3-methyl-2-buten-1-ol acetate as a reaction product from said first reaction mixture; and (c) forming a second reaction mixture of 4-halo-3-methyl-2-buten-1-ol acetate and dimethyl sulfoxide; (d) isolating E-4-acetoxy-2-methyl-2-butenal as a reaction product from said second reaction mixture. More specifically, the particular steps employed in successful practice of the invention may involve the following in sequence:
- N-bromosuccinimide was employed as the source of positive halogen in Example I, it is known that hypohalites such as tert-butyl hypochlorite may also be employed.
- the source of positive halogen can be an N-halosuccinimide or a hypohalite.
- suitable non-nucleophilic bases other than sodium bicarbonate e.g., 2,4,6-trimethylpyridine (collidine)] may be employed in the synthesis illustrated in Example IV.
- the DMSO oxidation proceeds much more favorably when a dibasic metal phosphate is used as the non-nucleophilic catalyst (Example V).
- a dibasic metal phosphate is used as the non-nucleophilic catalyst (Example V).
- all reactions may proceed at room temperature and under atmospheric pressure, although the formation and oxidation of primary chlorides is facilitated by use of moderate elevated temperatures (50° to 80°). It is expected, however, that obvious variations in these reaction conditions may be desirable for large scale production, and such alterations are within the contemplation of the invention.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
E-4-acetoxy-2-methyl-2-butenal is prepared by: (1) preparation of an intermediate allylic halide from isoprene; and (2) reaction of the allylic halide with dimethyl sulfoxide in the presence of a non-nucleophilic base to form the desired product.
Description
This application is a continuation-in-part of applicant's co-pending application--Ser. No. 871,075, filed Jan. 20, 1978, now abandoned, entitled, "Method of Preparing E-4-acetoxy-2-methyl-2-butenal."
Reif et al. have described a commercial process for the production of Vitamin A acetate [Chemie-Ing.-Techn. 45, 646-652 (1973)]. The final step of the synthesis involves a reaction between a C15 triphenylphosphonium salt and a C5 acetate: ##STR1## As a method for preparing the C5 acetate (i.e., β-formylcrotyl acetate, systematically named E-4-acetoxy-2-methyl-2-butenal) for use in the above reaction, Reif et al. show a multi-step process involving an oxidation reaction: ##STR2## The Reif et al. synthesis is suggested in U.S. Pat. No. 3,478,060, and in the references cited therein.
Another process for synthesizing the C5 acetate has been described in the recent literature by Wehrli et al. [Synthesis, 9, 649-50 (Sept. 1977)]. Wehrli's reaction involves a nitroacetoxylation of isoprene followed by a reduction of the resultant nitro acetate with iron in the presence of acetic acid. Overall yields of 40% of desired C5 acetate are reported. The reaction involves the use of heat and a potentially hazardous compound, acetyl nitrate.
The present invention relates to an improved process for producing E-4-acetoxy-2-methyl-2-butenal, a C5 acetate which can be used in Vitamin A synthesis. In one embodiment, practice of the method of the invention utilizes easily available isoprene and acetic acid as starting materials, proceeds at room temperature, requires only two reaction steps, and yields substantially quantitative amounts of the desired C5 acetate according to the following reaction scheme: ##STR3##
An initial step in applicant's process of synthesizing E-4-acetoxy-2-methyl-2-butenal involves the preparation of a 4-halo-3-methyl-2-buten-1-ol acetate intermediate. This intermediate may be prepared directly, in a one-step reaction by the addition of a source of positive halogen, X+, to a solution of isoprene in acetic acid according to a process described by applicant and his co-worker [J. Babler and W. Buttner, Tetrahedron Lett., 239 (1976)]. Compounds providing suitable sources of positive halogen for this reaction include acid solutions of N-bromosuccinimide or a hypochlorite such as tert-butyl hypochlorite, as illustrated in the following reactions. ##STR4## The first reaction yields approximately 75% by weight of the allylic halide as the desired 1,4 adduct and 25% as a 1,2 adduct. Both the 1,4 adduct (systematically named 4-bromo-3-methyl-2-buten-1-ol acetate) and the 1,2 adduct (1-bromo-2-acetoxy-2-methyl-3-butene) are readily separable both from the reaction mixture and from one another by fractional distillation.
Yield of the desired 1,4 adduct can be further enhanced. The isolated 1,2 adduct, in the presence of a strong acid catalyst, will be quantitatively isomerized to the desired 4-bromo-3-methyl-2-buten-1-ol acetate. A similar isomerization was reported by W. Oroshnik and R. A. Mallory [J. Amer. Chem. Soc., 72, 4608 (1950)].
Another method of synthesizing the 4-halo-3-methyl-2-buten-1-ol acetate which should offer economic advantages over the foregoing direct reactions, utilizes two reaction steps. The first step involves the synthesis of 1-chloro-2-methyl-3-buten-2-ol, which may be synthesized from isoprene in accordance with a process suggested in British Patent 978,892 to Dunlop Rubber Company: ##STR5## Another route to this intermediate is suggested elsewhere in the literature [Chem. Abstracts, 80, 59,36ly (1974)].
This resultant 1-chloro-2-methyl-3-buten-2-ol may be rearranged to the desired 4-chloro-3-methyl-2-buten-1-ol acetate intermediate by means of an isomerization reaction such as that suggested by applicant in U.S. Pat. No. 3,927,076. ##STR6##
The optimum route to the desired product, E-4-acetoxy-2-methyl-2-butenal, depends on which primary halide intermediate is used. Thus, when the primary bromide, 4-bromo-3-methyl-2-buten-1-ol acetate, is employed, the product may be obtained directly by the addition of dimethyl sulfoxide (DMSO) in the presence of a non-nucleophilic base such as sodium bicarbonate. The oxidation reaction proceeds at room temperature with yields of aldehyde in excess of 80%. ##STR7##
In the case of the primary allylic chloride, although DMSO and a bicarbonate base can be used to oxidize the allylic chloride, the reaction does not proceed at room temperature nor does it provide as quantitative a result as that involving the primary bromide. The yield of desired C5 acetate is moderate (˜ 40-50%) and unidentified by-products are formed which are not present in significant amounts when 4-bromo-3-methyl-2-buten-1-ol acetate is oxidized with DMSO in the presence of the bicarbonate.
However, the DMSO oxidation of the primary allylic chloride to the desired β-formylcrotyl acetate will be successful when a different non-nucleophilic base is utilized in the reaction--a dibasic metal phosphate such as Na2 HPO4 or K2 HPO4 : ##STR8## Use of a bromide salt such as sodium bromide and a monobasic metal phosphate buffer is desirable, but not necessary.
Although the oxidation of a primary alkyl halide by dimethyl sulfoxide to form an aldehyde is a known reaction, applicant has found no report in the literature of the successful use of dimethylsulfoxide under "SN2-type" conditions for oxidation of an allylic halide. This gap in the literature is no doubt attributable to the expectation that DMSO treatment of allylic halides would generate an elimination reaction (I→II) ##STR9## rather than follow an oxidation route, as is required to form an aldehyde.
Indeed, applicant has found that when numerous primary allylic bromides are reacted under the same conditions utilized according to the invention to form the desired C5 acetate, the products consist almost exclusively of elimination products of general structure II. Primary allylic bromides tested in this manner include 1-bromo-2-octadecene, 1-bromo-3-propyl-2-hexene, and 1-bromo-3, 7-dimethyl-2,6-octadiene (geranyl bromide). The result, in each case, was the formation of a conjugated 1,3diolefinic structure rather than the formation of the aldehyde.
Similar results are disclosed in a journal article by Ganem et al., Tetrahedron Lett., 917-20 (1974), where it is reported that the reaction of a primary allylic halide such as 1,4-dibromo-trans-2,3-dimethyl-2-butene with DMSO in the presence of a non-nucleophilic base fails to yield any dialdehyde under applicant's reaction conditions. These authors suggest that preparation of the aldehyde from primary allylic halides requires the use of a non-nucleophilic silver salt such as silver tetrafluoroborate, the initial step proceeding via a "SN1" reaction rather than an "SN2" reaction like applicant's.
The following examples illustrate in greater detail practice of the present invention and more specifically, (i) the formation of a desired 4-halo intermediate, 4-bromo-3-methyl-2-butene-1-ol acetate; (ii) the isomerization of a 1,2 adduct to the 1,4 adduct, 4-bromo-3-methyl-2-butene-1-ol acetate; (iii) the formation of another 4-halo intermediate, 4-chloro-3-methyl-2-butene-1-ol acetate; (iv) preparation of the desired C5 acetate, E-4-acetoxy-2-methyl-2-butenal from a primary allylic bromide; and (v) preparation of the desired C5 acetate from a primary allylic chloride.
93.6 g (526 mmoles) of N-bromosuccinimide (NBS) was added in portions over a period of 60 minutes to a well-stirred solution of 75 ml (0.73 mole) of isoprene in 300 ml of glacial acetic acid. After stirring this mixture at room temperature for an additional 30 minutes, it was diluted with 1,500 ml of water and the product was isolated by extraction with dichloromethane. The extracts were washed with saturated sodium bicarbonate solution, 10% sodium chloride solution, dried over anhydrous magnesium sulfate, and filtered. Removal of the dichloromethane by evaporation at reduced pressure yielded 108 g (99%) of crude product, which was subsequently separated into two components by fractional distillation:
Fraction 1: bp 65° at 3.0 mm; approximately 25 g (23%) was collected and shown to be the 1,2-adduct: ##STR10##
Fraction 2: bp 57°-65° (0.20 mm); 60.1 g (55%) of material was collected and shown to be the 1,4-adduct (as a 70:30 mixture of E:Z stereoisomers): ##STR11## 4-bromo-3-methyl-2-buten-1-ol acetate
In a larger-industrial-scale process, an alternative procedure could be used. After dilution of the mixture with water, the desired 1,2- and 1,4-adducts can be removed from the reaction mixture by continuous extraction with heptane or hexane. The acetic acid, in turn, can be removed from the remaining aqueous layer by continuous extraction with benzene, ether, or chloroform. The resultant aqueous layer will contain succinimide. If one equivalent of sodium hydroxide is added to the aqueous solution and the solution cooled to 0° C., addition of one equivalent of bromine will produce N-bromosuccinimide which quickly precipitates out of the aqueous medium and which may be recycled in the reaction.
A solution of 275 mg of 1,2 adduct in 6 ml of glacial acetic acid containing 1 ml of acetic anhydride and 100 mg of p-toluenesulfonic acid was allowed to stand at room temperature for 90 hours. The mixture was then diluted with 50 ml of water and the product was isolated by extraction with dichloromethane. The extracts were washed thoroughly with 1M aqueous NaOH, 10% aqueous sodium chloride, dried over anhydrous magnesium sulfate, and filtered. Removal of the dichloromethane by evaporation at reduced pressure afforded 159 mg (58%) of a product having IR and NMR spectra virtually identical to those of a pure sample of the 1,4 adduct.
Other strong acid catalysts (Ka ≧10-2) such as sulfuric acid can be used to effect this transformation.
Isoprene (4 moles) was added to bleaching powder (NaOCl, 0.85 mole) in 3500 ml of H2 O at 0°. The mixture was stirred and CO2 was passed into it for 4 hours. The product, 1-chloro-2-methyl-3-buten-2-ol, was isolated by continuous extraction with dichloromethane and was purified by simple distillation: bp 41°-2° C. at 11 mm.
A mixture of 240 mg. (1.26 mmoles) of p-toluene-sulfonic acid monohydrate in 1.0 ml of acetic anhydride and 5.0 ml of glacial acetic acid was added dropwise (with external cooling of the reaction mixture in a cold water bath) to a solution of 1.67 g. (13.86 mmoles) of 1-chloro-2-methyl-3-buten-2-ol and 1.0 ml of acetic anhydride in 6.0 ml of glacial acetic acid. This mixture was then heated at 55° C. (bath temperature) for 15 hours. The product was isolated by pouring the mixture into ice-cold aqueous sodium hydroxide (enough to neutralize the acetic acid) and extracting with ether. (The product can also be isolated by diluting the mixture with 10 volumes of iced water and continuous extraction with cyclohexane.) The yield of 1° allylic acetate (containing no 3° acetate) was 1.94 g. (11.94 mmoles, 86% yield).
A mixture of 1.10 g (5.3 mmoles) of 4-bromo-3-methyl-2-buten-1-ol acetate prepared according to Example I and 500 mg (5.95 mmoles) of sodium bicarbonate in 8 ml of anhydrous dimethyl sulfoxide was stirred vigorously at room temperature for approximately 20 hours. The product was isolated by diluting the mixture with 50 ml of H2 O and extracting thoroughly with dichloromethane. The combined extracts were washed with 10% sodium chloride solution, dried over anhydrous magnesium sulfate, and filtered. Removal of the dichloromethane by evaporation at reduced pressure, followed by chromatography on silica gel (elution with hexane--15% ether), afforded 0.61 g (81% yield) of the desired aldehyde. When a non-nucleophilic base (NaHCO3) was omitted from the reaction mixture, the oxidation reaction was not observed.
To a 25 ml flask equipped with an efficient stirrer and Vigreux column connected to a small distillation head were added 536 mg (3.3 mmole) of 4-chloro-3-methyl-2-buten-1-ol acetate, 4 ml of anhydrous dimethyl sulfoxide, 662 mg (3.80 mmole) of K2 HPO4 (potassium phosphate, dibasic), 138 mg (1.02 mmole) of KH2 PO4, and 40 mg (0.38 mmole) of sodium bromide. This mixture was then heated, protected from atmospheric moisture, at 80° C. (bath temperature) for 18 hours. The product was isolated by cooling the mixture to room temperature, pouring it into 40 ml of water, and extracting thoroughly with carbon tetrachloride. The yield of crude aldehyde was 452 mg (97% yield). GC analysis indicated the product was mainly a mixture of two components: >83% of this material was E-4-acetoxy-2-methyl-2-butenal (trans configuration for the double bond), and most of the rest was an unidentified, non-aldehydic compound (14 % of the mixture). This latter impurity is the same one produced when the oxidation is effected on the allylic bromide at room temperature, in accordance with the procedure of Example IV. Since it has a considerably higher boiling point than the desired aldehyde, simple fractional distillation can be used to separate the two compounds. The yield of the desired aldehyde, β-formylcrotyl acetate, after purification on a small scale by column chromatograhy on silica gel, is 82%--comparable to that obtained in Example IV at room temperature. It was also observed that the aldehyde product formed under the above conditions at 80° C. contained none of the stereoisomeric Z-4-acetoxy-2-methyl-2-butenal shown below: ##STR12##
The above examples indicate that the desired C5 acetate may be prepared by the general synthetic steps consisting of: (a) forming a first reaction mixture of isoprene, acetic acid, and a source of positive halogen; (b) isolating 4-halo-3-methyl-2-buten-1-ol acetate as a reaction product from said first reaction mixture; and (c) forming a second reaction mixture of 4-halo-3-methyl-2-buten-1-ol acetate and dimethyl sulfoxide; (d) isolating E-4-acetoxy-2-methyl-2-butenal as a reaction product from said second reaction mixture. More specifically, the particular steps employed in successful practice of the invention may involve the following in sequence:
(a) preparing in a vessel a room temperature solution of 1.4 parts of isoprene in ten parts of glacial acetic acid;
(b) adding one part of N-bromosuccinimide to said room temperature solution with constant stirring for a suitable time;
(c) adding to said vessel a quantity of water sufficient to increase the volume approximately five-fold whereby a dilute solution is formed;
(d) extracting said dilute solution with volumes of dichloromethane;
(e) washing said dichloromethane extracts with aqueous solutions of saturated sodium bicarbonate, 10% sodium chloride;
(f) drying said washed extracts with anhydrous magnesium sulfate and filtering said dried extracts;
(g) removing said dichloromethane from said filtered extracts by evaporation at reduced pressure whereby crude intermediate remains;
(h) fractionally distilling said crude intermediate at reduced pressure and elevated temperature;
(i) isolating the intermediate fraction having a boiling point at 0.20 mm of between 57° C. and 65° C.;
(j) adding said isolated intermediate fraction to a second reaction vessel containing a molar excess of anhydrous dimethyl sulfoxide and sodium bicarbonate;
(k) stirring said second reaction vessel at room temperature for 20 hours;
(l) adding a quantity of water sufficient to dilute the contents of said second vessel approximately six-fold;
(m) extracting the diluted contents of said second vessel with successive quantities of dichloromethane, washing and drying said extracts, and removing said dichloromethane by evaporation at reduced pressure; and
(n) isolating the desired product by the use of chromatography.
Numerous modifications and variations in the practice of the invention are expected to occur to those skilled in the art upon consideration of the foregoing examples.
Although N-bromosuccinimide was employed as the source of positive halogen in Example I, it is known that hypohalites such as tert-butyl hypochlorite may also be employed. The source of positive halogen can be an N-halosuccinimide or a hypohalite. Similarly, suitable non-nucleophilic bases other than sodium bicarbonate [e.g., 2,4,6-trimethylpyridine (collidine)] may be employed in the synthesis illustrated in Example IV.
However, in the case of the primary chlorides, the DMSO oxidation proceeds much more favorably when a dibasic metal phosphate is used as the non-nucleophilic catalyst (Example V). As noted previously, all reactions may proceed at room temperature and under atmospheric pressure, although the formation and oxidation of primary chlorides is facilitated by use of moderate elevated temperatures (50° to 80°). It is expected, however, that obvious variations in these reaction conditions may be desirable for large scale production, and such alterations are within the contemplation of the invention.
The foregoing detailed description has been given for clearness of understanding only and no unnecessary limitations should be understood therefrom, as modifications will be obvious to those skilled in the art.
Claims (10)
1. A process for synthesis of E-4-acetoxy-2-methyl-2-butenal comprising the following steps in sequence:
(a) forming a reaction mixture of 4-halo-3-methyl-2-buten-1-ol acetate, dimethyl sulfoxide, and a non-nucleophilic base;
(b) isolating E-4-acetoxy-2-methyl-2-butenal as a reaction product from said reaction mixture.
2. A process for synthesis of E-4-acetoxy-2-methyl-2-butenal comprising the following steps in sequence:
(a) forming a first reaction mixture of isoprene, acetic acid and a source of positive halogen;
(b) isolating 4-halo-3-methyl-2-buten-1-ol acetate as a reaction product from said first reaction mixture; and
(c) forming a second reaction mixture of 4-halo-3-methyl-2-buten-1-ol acetate, dimethyl sulfoxide, and a non-nucleophilic base;
(d) isolating E-4-acetoxy-2-methyl-2-butenal as a reaction product from said second reaction mixture.
3. The process of claim 2 wherein said source of positive halogen is a member selected from the group consisting of N-halosuccinimide or a hypohalite.
4. The process of claim 2 wherein said non-nucleophilic base is sodium bicarbonate.
5. The process of claim 2 wherein said source of positive halogen is N-bromosuccinimide and said reaction product isolated from said first reaction mixture is 4-bromo-3-methyl-2-buten-1-ol acetate.
6. The process of claim 5 further including the following steps in sequence:
(a) isolating 1-bromo-2-acetoxy-2-methyl-3-butene as a reaction product from said first reaction mixture; and
(b) forming a third reaction mixture of 1-bromo-2-acetoxy-2-methyl-3-butene, an acid catalyst, and acetic acid; and
(c) isolating 4-bromo-3-methyl-2-buten-1-ol acetate as a reaction product from said third reaction mixture.
7. The process of claim 6 wherein said acid catalyst is selected from the group consisting of p-toluene-sulfonic acid, and sulfuric acid.
8. A process for synthesis of E-4-acetoxy-2-methyl-2-butenal comprising the following steps in sequence:
(a) forming a first reaction mixture comprising an aqueous solution of isoprene, a hypochlorite, and a stream of gaseous carbon dioxide;
(b) isolating 1-chloro-2-methyl-3-buten-2-ol as a reaction product from said first reaction mixture; and
(c) forming a second reaction mixture of 1-chloro-2-methyl-3-buten-2-ol, acetic acid, acetic anhydride and a strong acid catalyst;
(d) isolating 4-chloro-3-methyl-2-buten-1-ol acetate as a reaction product from said second reaction mixture; and
(e) forming a third reaction mixture of 4-chloro-3-methyl-2-buten-1-ol acetate, dimethyl sulfoxide, and a non-nucleophilic base selected from the group consisting of dibasic sodium phosphate and dibasic potassium phosphate;
(f) isolating E-4-acetoxy-2-methyl-2-butenal as a reaction product from said third reaction mixture.
9. The process of claim 8 further including in said third reaction mixture a bromide salt.
10. The process of claim 9 further including in said third reaction mixture a phosphate buffer.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/001,075 US4175204A (en) | 1978-01-20 | 1979-01-08 | Method of preparing E-4-acetoxy-2-methyl-2-butenal |
| PCT/US1979/000028 WO1979000485A1 (en) | 1978-01-20 | 1979-01-16 | Method of preparing e-4-acetoxy-2-methyl-2-butenal |
| EP79900203A EP0008581A1 (en) | 1978-01-20 | 1979-07-31 | Method of preparing e-4-acetoxy-2-methyl-2-butenal |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87107578A | 1978-01-20 | 1978-01-20 | |
| US06/001,075 US4175204A (en) | 1978-01-20 | 1979-01-08 | Method of preparing E-4-acetoxy-2-methyl-2-butenal |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US87107578A Continuation-In-Part | 1978-01-20 | 1978-01-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US4175204A true US4175204A (en) | 1979-11-20 |
Family
ID=26668518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US06/001,075 Expired - Lifetime US4175204A (en) | 1978-01-20 | 1979-01-08 | Method of preparing E-4-acetoxy-2-methyl-2-butenal |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US4175204A (en) |
| EP (1) | EP0008581A1 (en) |
| WO (1) | WO1979000485A1 (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4579977A (en) * | 1984-12-20 | 1986-04-01 | Phillips Petroleum Company | Process for the oxidation of organic halides to organic aldehydes |
| US4916250A (en) * | 1988-10-31 | 1990-04-10 | Loyola University Of Chicago | Phosphonate reagent compositions |
| US5061819A (en) * | 1988-10-31 | 1991-10-29 | Loyola University Of Chicago | Methods for synthesizing phosphonate reagents and retinoids |
| US5471004A (en) * | 1993-06-14 | 1995-11-28 | Takeda Chemical Industries, Ltd. | Process for producing α,β-unsaturated aldehydes |
| US5527952A (en) * | 1993-06-14 | 1996-06-18 | Takeda Chemical Industries, Ltd. | Process for producing aldehyde derivatives |
| US5905175A (en) * | 1998-05-20 | 1999-05-18 | The Nutrasweet Company | Synthesis and purification of 3,3-dimethylbutyraldehyde via oxidation of 1-chloro-3,3-dimethylbutane with dimethyl sulfoxide |
| EP1231197A1 (en) * | 2001-02-07 | 2002-08-14 | Sumitomo Chemical Company, Limited | Process for producing allyl halide compound |
| US6573409B1 (en) | 1999-07-02 | 2003-06-03 | The Nutrasweet Company | Process for the preparation of 3,3-dimethylbutanal |
| US6660888B2 (en) | 2000-10-18 | 2003-12-09 | Sumitomo Chemical Company, Limited | Process for producing retinol and intermediate compounds for producing the same |
| CN112321421A (en) * | 2020-09-29 | 2021-02-05 | 宿迁科思化学有限公司 | Preparation method of 1-acetoxyl-4-chloro-3-methyl-2-butene |
| CN114000170A (en) * | 2021-12-01 | 2022-02-01 | 万华化学集团股份有限公司 | Method for preparing 4-acetoxyl-2-methyl-2-butene-1-aldehyde |
| CN114907212A (en) * | 2022-06-30 | 2022-08-16 | 万华化学集团股份有限公司 | Preparation method of vitamin A intermediate |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3639562A1 (en) * | 1986-11-20 | 1988-06-01 | Basf Ag | METHOD FOR PRODUCING 2-SUBSTITUTED 4-ACYLOXI-2-BUTENALEN |
| CN102311339B (en) * | 2011-06-30 | 2014-06-04 | 绍兴文理学院 | Method for preparing 4-acetoxy-2-methyl-2-butene-1-aldehyde |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2511870A (en) * | 1945-12-08 | 1950-06-20 | Ortho Pharmaceutical Corp. | Method for producing esters of isoprene halohydrins |
| GB736488A (en) * | 1952-12-24 | 1955-09-07 | Roussel Uclaf | Process for the preparation of an unsaturated aldehyde |
| US3213155A (en) * | 1961-05-19 | 1965-10-19 | Exxon Research Engineering Co | Monoolefin isomerization process |
| US4048220A (en) * | 1975-05-30 | 1977-09-13 | Scm Corporation | Process for preparation of 1,4-haloallylic esters from dienes |
-
1979
- 1979-01-08 US US06/001,075 patent/US4175204A/en not_active Expired - Lifetime
- 1979-01-16 WO PCT/US1979/000028 patent/WO1979000485A1/en not_active Ceased
- 1979-07-31 EP EP79900203A patent/EP0008581A1/en not_active Withdrawn
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2511870A (en) * | 1945-12-08 | 1950-06-20 | Ortho Pharmaceutical Corp. | Method for producing esters of isoprene halohydrins |
| GB736488A (en) * | 1952-12-24 | 1955-09-07 | Roussel Uclaf | Process for the preparation of an unsaturated aldehyde |
| US3213155A (en) * | 1961-05-19 | 1965-10-19 | Exxon Research Engineering Co | Monoolefin isomerization process |
| US4048220A (en) * | 1975-05-30 | 1977-09-13 | Scm Corporation | Process for preparation of 1,4-haloallylic esters from dienes |
Non-Patent Citations (2)
| Title |
|---|
| Babler et al., Tetrahedron Letters, 239 (1976). * |
| Ganem, Tetrahedron Letters, 917-920 (1974). * |
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4579977A (en) * | 1984-12-20 | 1986-04-01 | Phillips Petroleum Company | Process for the oxidation of organic halides to organic aldehydes |
| US4916250A (en) * | 1988-10-31 | 1990-04-10 | Loyola University Of Chicago | Phosphonate reagent compositions |
| US5061819A (en) * | 1988-10-31 | 1991-10-29 | Loyola University Of Chicago | Methods for synthesizing phosphonate reagents and retinoids |
| US5471004A (en) * | 1993-06-14 | 1995-11-28 | Takeda Chemical Industries, Ltd. | Process for producing α,β-unsaturated aldehydes |
| US5527952A (en) * | 1993-06-14 | 1996-06-18 | Takeda Chemical Industries, Ltd. | Process for producing aldehyde derivatives |
| US5905175A (en) * | 1998-05-20 | 1999-05-18 | The Nutrasweet Company | Synthesis and purification of 3,3-dimethylbutyraldehyde via oxidation of 1-chloro-3,3-dimethylbutane with dimethyl sulfoxide |
| JP2002515471A (en) * | 1998-05-20 | 2002-05-28 | ザ・ニユートラスウイート・カンパニー | Synthesis and purification of 3,3-dimethylbutyraldehyde by oxidation of 1-chloro-3,3-dimethylbutane with dimethylsulfoxide |
| US20040006247A1 (en) * | 1999-07-02 | 2004-01-08 | The Nutrasweet Company | Process for the preparation of 3, 3-dimethylbutanal |
| US6803487B2 (en) | 1999-07-02 | 2004-10-12 | The Nutrasweet Company | Process for the preparation of 3,3-dimethylbutanal |
| US7348459B2 (en) | 1999-07-02 | 2008-03-25 | The Nutrasweet Company | Process for the preparation of 3,3-dimethylbutanal |
| US20070106086A1 (en) * | 1999-07-02 | 2007-05-10 | The Nutrasweet Company | Process for the preparation of 3,3-dimethylbutanal |
| US6573409B1 (en) | 1999-07-02 | 2003-06-03 | The Nutrasweet Company | Process for the preparation of 3,3-dimethylbutanal |
| US7164049B2 (en) | 1999-07-02 | 2007-01-16 | The Nutrasweet Company | Process for the preparation of 3,3-dimethylbutanal |
| US20040082814A1 (en) * | 2000-10-18 | 2004-04-29 | Sumitomo Chemical Company, Limited | Process for producing retinol and intermediate compounds for producing the same |
| US6784321B2 (en) | 2000-10-18 | 2004-08-31 | Sumitomo Chemical Company, Limited | Process for producing retinol and intermediate compounds for producing the same |
| US6660888B2 (en) | 2000-10-18 | 2003-12-09 | Sumitomo Chemical Company, Limited | Process for producing retinol and intermediate compounds for producing the same |
| EP1231197A1 (en) * | 2001-02-07 | 2002-08-14 | Sumitomo Chemical Company, Limited | Process for producing allyl halide compound |
| CN112321421A (en) * | 2020-09-29 | 2021-02-05 | 宿迁科思化学有限公司 | Preparation method of 1-acetoxyl-4-chloro-3-methyl-2-butene |
| CN114000170A (en) * | 2021-12-01 | 2022-02-01 | 万华化学集团股份有限公司 | Method for preparing 4-acetoxyl-2-methyl-2-butene-1-aldehyde |
| CN114907212A (en) * | 2022-06-30 | 2022-08-16 | 万华化学集团股份有限公司 | Preparation method of vitamin A intermediate |
| CN114907212B (en) * | 2022-06-30 | 2023-08-11 | 万华化学集团股份有限公司 | A kind of preparation method of vitamin A intermediate |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0008581A1 (en) | 1980-03-05 |
| WO1979000485A1 (en) | 1979-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4175204A (en) | Method of preparing E-4-acetoxy-2-methyl-2-butenal | |
| Uno | Allylation of 2-alkanoyl 1, 4-quinones with allylsilanes and allylstannanes. Efficient synthesis of pyranonaphthoquinone antibiotics | |
| US4310709A (en) | Manufacture of but-2-en-1-ol compounds by isomerizing the corresponding but-3-en-1-ol compounds | |
| DePuy et al. | Chemistry of cyclopropanols. VI. Cleavage by electrophilic halogen | |
| EP0234496B2 (en) | Process for preparing alpha, beta-unsaturated aldehydes | |
| Hegedus et al. | Cobalt-mediated synthesis of nitro enones from 1, 3-dienes and alkylnitronates | |
| Scott et al. | Aliphatic diazo ketones. A modified synthesis requiring minimal diazomethane | |
| CA1160641A (en) | Ambrinol and its homologues | |
| Sardessai et al. | THE BROMINATION OF 2, 5-DIMETHOXYBENZALDEHYDE. STRUCTURAL PROOF OF THE 6-BROMO ISOMER via 3, 6-DIMETHOXYBENZOCYCLOBUTENE | |
| US3935205A (en) | Dimorpholinomethyl-(4-methyl-3-pentenyl)-cyclohexenenes | |
| JP4418048B2 (en) | Process for producing 13-cis-retinoic acid | |
| US4302607A (en) | Process for the preparation of novel unsaturated macrocyclic ketones | |
| US4665244A (en) | Chlorinated derivatives of hexadecene, their preparation and their use in the synthesis of vitamin E | |
| Elfehail et al. | . alpha.-Nitro ketones. 5. Synthesis of 2-nitrocyclopentanones | |
| US4634778A (en) | Process for preparing chlorinated ethylenic derivatives | |
| US3413351A (en) | 1, 1-dimethyl-2-(3-oxo-butyl-1) cyclopropane | |
| Ginsburg et al. | 109. Preliminary syntheses in the morphine series. Part II. The synthesis of 2-aryl cyclo hex-2-enones | |
| Naoshima et al. | A New Synthesis of γ-Jasmolactone and Its Dihydroderivative | |
| US5243097A (en) | Process for the continuous bulk production of acrylic polymers | |
| US2369167A (en) | Synthesis of vitamin a | |
| JP2502936B2 (en) | Novel acetylene derivative | |
| CH516494A (en) | Olefinic alcohols prodn - by rearrangement of olefinic ethers | |
| Odinokov et al. | Insect pheromones and their analogs. XV. The synthesis of 9-oxodec-2E-enoic acid—A pheromone of the honeybee Apis melliferana | |
| US5231232A (en) | Method of preparing C-18 ketones used in the manufacture of Vitamins E and K | |
| Yamamitsu et al. | Synthesis of 4-and 5-regioselectively deuteriated geranyl diphosphates |